• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 1 Device Recall UniCel DxH 900 Coulter Cellular Analysis System

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 1 Device Recall UniCel DxH 900 Coulter Cellular Analysis System see related information
Date Initiated by Firm July 30, 2018
Date Posted May 23, 2019
Recall Status1 Terminated 3 on March 31, 2022
Recall Number Z-1384-2019
Recall Event ID 82329
510(K)Number K140911  
Product Classification Counter, differential cell - Product Code GKZ
Product UniCel DxH 900 Coulter Cellular Analysis System, REF number C11478

Product Usage:
Note: The DxH 900 hematology analyzer is CLIA categorized under document CR180294 and is currently marketed as a member of the instrument family of the DxH 800 cleared under K140911, per FDA s guidance, Guidance for Industry and FDA Staff, Replacement Reagent and Instrument Family Policy . DxH 800 intended use states: The UniCel DxH 800 Analyzer is a quantitative multi-parameter, automated hematology analyzer for in vitro diagnostic use in screening patient populations found in clinical laboratories. The UniCel¿ DxH 800 Analyzer identifies and enumerates the parameters indicated below on the following sample types: Whole Blood (Venous and Capillary) o WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, RDW-SD, PLT, MPV, NE%, NE#, LY%, LY#, MO%, MO#, EO%, EO#, BA%, BA#, NRBC%, NRBC#, RET%, RET#, MRV, IRF Pre-Diluted Whole Blood (Venous and Capillary) o WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, RDW-SD, PLT, MPV Body Fluids (cerebrospinal, serous and synovial) o TNC and RBC
Code Information All current software versions are impacted
Recalling Firm/
Manufacturer
Beckman Coulter Inc.
250 S Kraemer Blvd
Brea CA 92821-6232
For Additional Information Contact Mr. Christopher Riley
714-993-5321
Manufacturer Reason
for Recall
Complaints received of sporadic erroneously elevated platelet results without flags or system messages. Thrombocytopenia may go unrecognized.
FDA Determined
Cause 2
Software Design Change
Action Urgent Medical Device Recall letters, dated July 30, 2018, were sent via email and postal mail on August 1, 2018 (for those customers not on their email notification system). On 05/22/19, second Urgent Medical Device (UMDC) Recall letters, and Important Safety Information notices, dated May 20, 2019 (replacing BEC UMDC letter dated July 30, 2018), were sent via mail and/or phone and/or e-mail informing customers perform the following actions: - Run samples on an instrument not subject to this recall to confirm the platelet results. - If an alternative instrument is not available, use the following quality control measures to aid in identification of discrepant platelet results: a) Perform manual scanning/estimate of platelets on a peripheral smear and compare with instrument results. Note that this method will identify samples with marked to moderate thrombocytopenia but may not identify smaller discrepancies. b) Repeat testing of samples in a workflow configuration may facilitate the identification of discrepancies. If an erroneous result is detected, review results from adjacent samples, i.e., those tested on the instrument both before and after the erroneous result. c) Additional instrument and/or LIS features including reference ranges, XM (exponentially-weighted moving average) and delta checks may be informative. d) Follow your laboratory's standard operating procedure to confirm unexpected results. - Ongoing investigation indicates that the probable root cause is the sweep flow disruption that may occur following the "Clear RBC Apertures" procedure. This potential root cause is currently under further investigation. Customers should discontinue using this procedure. If you suspect that your instrument has a clogged aperture that will not clear, discontinue use of the analyzer, contact Customer Support Center and request service. - Communicate to the ordering physicians the need to avoid patient treatment based solely on any single test resu
Quantity in Commerce 341
Distribution Worldwide Distribution - US Nationwide including Puerto Rico. There was government and military distribution. Foreign distribution was made to Andorra, Australia, Austria, Belgium, Canada, China, Croatia, Egypt, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Kuwait, Latvia, Lithuania, Mexico, Morocco, Myanmar, Netherlands Antilles, New Zealand, Portugal, Romania, Russia, Saudi Arabia, Serbia, Slovenia, Spain, Switzerland, Trinidad and Tobago, U.A.E, United Kingdom, and Vietnam.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database 510(K)s with Product Code = GKZ and Original Applicant = BECKMAN COULTER, INC.
-
-